These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 2220795)

  • 21. Calcium antagonists and the kidney: future therapeutic perspectives.
    Epstein M
    Am J Kidney Dis; 1993 Jun; 21(6 Suppl 3):16-25. PubMed ID: 8503430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal actions of calcium antagonists.
    Sterzel RB
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S17-22. PubMed ID: 2455125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcium antagonists and renal protection. Current status and future perspectives.
    Epstein M
    Arch Intern Med; 1992 Aug; 152(8):1573-84. PubMed ID: 1497390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modification of the renal hemodynamic response to vasoconstrictors by calcium antagonists.
    Loutzenhiser R; Epstein M
    Am J Nephrol; 1987; 7 Suppl 1():7-16. PubMed ID: 3442293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ca2+ channel subtypes and pharmacology in the kidney.
    Hayashi K; Wakino S; Sugano N; Ozawa Y; Homma K; Saruta T
    Circ Res; 2007 Feb; 100(3):342-53. PubMed ID: 17307972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcium antagonists and the kidney.
    Chellingsworth M; Kendall MJ
    J Hum Hypertens; 1987 Jun; 1(1):3-8. PubMed ID: 3334055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of amlodipine on renal hemodynamics.
    Loutzenhiser RD; Epstein M; Fischetti F; Horton C
    Am J Cardiol; 1989 Nov; 64(17):122I-127I; discussion 127I-128I. PubMed ID: 2530883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcium antagonists and the renal hemodynamic response to vasoconstrictors.
    Loutzenhiser R; Epstein M
    Ann N Y Acad Sci; 1988; 522():771-84. PubMed ID: 3377380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcium antagonists and renal failure progression.
    Robles NR
    Ren Fail; 2008; 30(3):247-55. PubMed ID: 18350443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal haemodynamic and protective effects of calcium antagonists in hypertension.
    Zanchi A; Brunner HR; Waeber B; Burnier M
    J Hypertens; 1995 Dec; 13(12 Pt 1):1363-75. PubMed ID: 8866898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dihydropyridine calcium antagonists and agonists in the isolated perfused Dahl rat kidney.
    Steele TH; Challoner-Hue L
    J Cardiovasc Pharmacol; 1987; 9 Suppl 1():S44-8. PubMed ID: 2441184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of calcium antagonists on glomerular hemodynamics and structure in experimental hypertension.
    Dworkin LD
    Am J Kidney Dis; 1991 May; 17(5 Suppl 1):89-93. PubMed ID: 2024683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The renal effects of calcium antagonists].
    Schulte KL; Lenz T
    Dtsch Med Wochenschr; 1993 Sep; 118(36):1293-300. PubMed ID: 8375300
    [No Abstract]   [Full Text] [Related]  

  • 34. [Renal protective effects of calcium antagonists].
    Musialik D; Raszeja-Wanic B; Tylarski A
    Pol Merkur Lekarski; 1996 Oct; 1(4):266-70. PubMed ID: 9156942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are differences in calcium antagonists relevant across all stages of nephropathy or only proteinuric nephropathy?
    Segura J; García-Donaire JA; Ruilope LM
    Curr Opin Nephrol Hypertens; 2007 Sep; 16(5):422-6. PubMed ID: 17693756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal protection with calcium antagonism in essential hypertension.
    Bauer JH; Reams GP
    Clin Invest Med; 1989 Oct; 12(5):300-4. PubMed ID: 2689026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal protection with the calcium antagonists.
    Neumayer HH; Kunzendorf U
    J Cardiovasc Pharmacol; 1991; 18 Suppl 1():S11-8. PubMed ID: 1723449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcium antagonists and the kidney.
    Pearce CJ; Wallin JD
    New Horiz; 1996 Feb; 4(1):123-8. PubMed ID: 8689267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nephroprotection by antihypertensive agents.
    Schmieder RE
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S55-64. PubMed ID: 7898095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of calcium channel blockers on experimental glomerular injury.
    Dworkin LD
    J Am Soc Nephrol; 1990 Sep; 1(3 Suppl 1):S21-7. PubMed ID: 16989074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.